Clinical Safety Considerations and Provider Guidance GLP-1 medications are contraindicated in patients with personal or family history of medullary thyroid carcinoma, severe pancreatitis, or uncontrolled diabetic retinopathy
Similarly, post-translational modification of membrane proteins such as SLAC1 and RBOHD/F underlines the systems capacity for rapid physiological modulation
However, the EMPA-REG OUTCOME trial with empagliflozin, the DECLARE-TIMI 58 trial with dapagliflozin, and the VERTIS CV trial with ertuglifozin did not report an increase in amputations in the patients treated with an SGLT2 inhibitor (143,156,160,230)
PlexusDx offers both as compounded injections, allowing your doctor to choose the option best suited to your genetic makeup and weight loss goals
DOI: 10.1016/j.nut.2015.09.003
Almost everyone wants more weight loss, and I am learning in real time how to best support patients who have reached a weight loss plateau at a weight that is higher than they hoped at the start of treatment